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Methods: Experimental OA was induced by intra-articular injec-
tion of MIA into right hind knee of male Wistar rats. Mechanical
hyperalgesia and knee joint pain were measured by von Frey ﬁla-
ment and Incapacitance Tester, respectively. First, we examined
the dose- and the time-dependency of analgesic effect of single
administration of Neurotropin on the pain of MIA-induced OA
rats. To clarify the effects of repetitive dosing on OA pain, Neu-
rotropin at doses of 100 or 200 NU/kg was orally administered to
MIA-induced OA rats from day 7 to day 28. Furthermore, repet-
itive oral administrations of Neurotropin (200 NU/kg), loxoprofen
(2 mg/kg), or meloxicam (2 mg/kg) were carried out from day 7
to day 21, and mechanical hyperalgesia and knee joint pain were
measured at 24 hours after Neurotropin administration. To clarify
the action mechanisms of Neurotropin, antagonists for receptor
of alpha2 noradrenergic, 5-HT2A, or 5-HT3 related with descend-
ing pain inhibitory pathways were intrathecally administered at
45 minutes after Neurotropin treatment, and then mechanical
hyperalgesia was measured at 15 minutes after administration of
antagonists.
Results: MIA at doses of 0.3, 1.0, 3.0 mg/site developed me-
chanical hyperalgesia and knee joint pain in a dose dependent
manner. The single administration of Neurotropin (100, 200, 400
NU/kg) ameliorated mechanical hyperalgesia of OA rats in a dose
dependent manner. This antinociceptive effect of Neurotropin at
a dose of 200 NU/kg was reached to a peak at 1 hour and
disappeared at 24 hour after Neurotropin treatment. However,
the single dose of Neurotropin was not ameliorated knee joint
pain of OA rats. In comparison, repetitive oral administration of
Neurotropin signiﬁcantly ameliorated not only mechanical hyper-
algesia but also knee joint pain of OA rats even at 24 hour
after Neurotropin treatment. Repetitive oral administration of lox-
oprofen or meloxicam was signiﬁcantly ameliorated mechanical
hyperalgesia and knee joint pain as well as Neurotropin treat-
ment. However, repetitive treatment of loxoprofen or meloxicam
induced gastro mucosal injury, but Neurotropin did not. The
inhibitory effect of single dose of Neurotropin on mechanical
hyperalgegia of OA was blocked by intrathecal injection of 30
nmol of yohimbine (alpha2 noradrenaline receptor antagonist),
100 nmol of ketanserin (5-HT2A receptor antagonist), or 30 nmol
of MDL72222 (5-HT3 receptor antagonist).
Conclusions: These results indicate that the analgesic effect
of Neurotropin on chronic pain of MIA-induced OA rats is com-
parable to NSAIDs and Neurotropin is safer than NSAIDs. The
descending pain inhibitory pathway might be involved in the
analgesic effect of Neurotropin on mechanical hyperalgesia of
MIA-induced OA rats.
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Purpose: Pain in osteoarthritis (OA) is exacerbated both by
movement and by weight bearing on the affected joint. To in-
vestigate the occurrence and the time-course of pain related
behaviours in an experimental model of OA, we used the knee
bend, CatWalk (CW) and pin-prick tests, as well the von Frey
and Randall-Selitto tests.
Methods: OA was induced by injection of mono-iodoacetate
(MIA), in the left knee joint of adult male Wistar rats, at doses of
2 or 3 mg/joint. Control animals received a similar injection with
saline. Paw withdrawal thresholds (PWT) to von Frey ﬁlaments
and Randall-Selitto, score of knee-bend test, hind paw-print
intensity (assessed using a CW apparatus and expressed as
total intensity of the ipsilateral paw as a percentage of the total
intensity of both hindpaws) and paw withdrawal latency (PWL)
to pin-prick test were measured before the induction of OA and
on various days for up to 31 days post-injection of MIA, on both
sides.
Results: In every time point studied, PWT values and the hind-
paw load distribution of OA rats were signiﬁcantly smaller than
those observed for the control group (P<0.01 and P<0.05,
respectively), reﬂecting a mechanical allodynia. Similarly, the
knee-bend score for the OA groups showed signiﬁcantly higher
values when compared to the control animals (P<0.05), indica-
tive of the animal’s allodynia and hyperalgesia. No signiﬁcant
difference was observed between the two OA groups in any of
these tests, as well as no signiﬁcant differences were observed
in the Randall-Selitto and pin-prick test between the OA and the
control animals.
Conclusions: We conclude that the catwalk and knee-bend test
are very useful and effective methods for evaluating movement
pain and disability induced by this experimental model of OA
in the rat, and are better predictors of the animal allodynia and
hyperalgesia than the Randall-Selitto and pin-prick tests.
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Purpose: Mitochondria are involved in many cellular processes,
and mitochondrial dysfunctions have been associated with apop-
tosis, aging and a number of pathological conditions, including
osteoarthritis (OA). Mitochondrial proteins are an attractive tar-
get to study the metabolism of chondrocyte and its role in the
cartilage degradation. Using a proteomic approach, we have an-
alyzed the mitochondrial protein changes that are characteristic
of OA chondrocytes, and we have identiﬁed by these means new
OA-related mitochondrial proteins.
Methods: Chondrocytes were obtained from 6 OA patients un-
dergoing joint replacement, and from 6 cartilages from autopsies
without history of joint disease. Mitochondria were isolated by
homogenization and differential centrifugation processes. Differ-
ential expression analysis was carried out using the differential
in-gel electrophoresis technology (DIGE). Brieﬂy, mitochondrial
proteins from control and OA samples were labelled with differ-
ent ﬂuorescent dyes, mixed by pairs and co-resolved by two-
dimensional gel electrophoresis using a pool of all samples as
internal standard. Gel images were acquired with the Typhoon
scanner, and biological variation analysis was performed using
the DeCyder 6.5 software. OA-related proteins were identiﬁed by
matrix-assisted laser desorption/ionization-time of ﬂight (MALDI-
TOF) or MALDI-TOF/TOF mass spectrometry. Extended statistic
and clustering analysis of the data was performed with the EDA
module of DeCyder software. Validation of the results was carried
out by Western blotting and immunoﬂuorescence analyses.
Results: We examined more than 1500 protein spots that were
present in the six different DIGE gels. Both qualitative and quan-
titative changes in protein expression patterns between normal
and OA chondrocyte mitochondria were studied. 36 protein spots
were found to be statistically increased in OA cells compared to
